Successful response to tralokinumab in patients unresponsive, intolerant or with contraindications to dupilumab and JAK inhibitors: A case series
Journal of the European Academy of Dermatology and Venereology · 2024
DOI: 10.1111/jdv.19929 ↗Kurz gefasst
Leserbrief in der Zeitschrift Journal of the European Academy of Dermatology and Venereology, 2024. Verfasst von Niccolò Gori und 21 weiteren Autor:innen. Beteiligte Einrichtung: Dermatologia, Dipartimento Universitario di Medicina e Chirurgia Traslazionale, Università Cattolica del Sacro Cuore, Rome, Italy. Hauptthemen laut MEDLINE: Antibodies, Monoclonal, Humanized, Janus Kinase Inhibitors. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 6 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Dermatologia, Dipartimento Universitario di Medicina e Chirurgia Traslazionale, Università Cattolica del Sacro Cuore, Rome, Italy.
- Dermatologia, Dipartimento di Scienze Mediche e Chirurgiche, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.
- Dermatology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
- Unit of Dermatology-University of Campania Luigi Vanvitelli, Naples.
- Section of Dermatology, Department of Medical Sciences, University of Turin, Turin, Italy.
- Section of Dermatology and Venereology, Department of Medicine, University of Verona, Verona, Italy.
ORCID-Profile: Niccolò Gori, Martina Maurelli, Marco Galluzzo, Monica Munera Campos, Lucia Di Nardo, Curdin Conrad, Jose Manuel Carrascosa, Giuseppe Argenziano, Simone Ribero, Giampiero Girolomoni, Angelo Valerio Marzano, Andrea Chiricozzi, Ketty Peris
Zitieren
APA
Gori, N., Ippoliti, E., Ferrucci, S. M., Balato, A., Ortoncelli, M., Maurelli, M., Galluzzo, M., Munera Campos, M., Seremet, T., Di Nardo, L., Antonelli, F., Coscarella, G., Conrad, C., Carrascosa, J. M., Bianchi, L., Argenziano, G., Ribero, S., Girolomoni, G., Marzano, A. V., …, & MEDaCoTRA Study Group (2024). Successful response to tralokinumab in patients unresponsive, intolerant or with contraindications to dupilumab and JAK inhibitors: A case series. Journal of the European Academy of Dermatology and Venereology. https://doi.org/10.1111/jdv.19929
Vancouver
Gori N, Ippoliti E, Ferrucci SM, Balato A, Ortoncelli M, Maurelli M, et al. Successful response to tralokinumab in patients unresponsive, intolerant or with contraindications to dupilumab and JAK inhibitors: A case series. Journal of the European Academy of Dermatology and Venereology. 2024. doi:10.1111/jdv.19929
BibTeX
@article{Gori2024,
author = {Gori, Niccolò and Ippoliti, Elena and Ferrucci, Silvia Mariel and Balato, Anna and Ortoncelli, Michela and Maurelli, Martina and Galluzzo, Marco and Munera Campos, Monica and Seremet, Teofila and Di Nardo, Lucia and Antonelli, Flaminia and Coscarella, Giulia and Conrad, Curdin and Carrascosa, Jose Manuel and Bianchi, Luca and Argenziano, Giuseppe and Ribero, Simone and Girolomoni, Giampiero and Marzano, Angelo Valerio and Chiricozzi, Andrea and Peris, Ketty and MEDaCoTRA Study Group, MEDaCoTRA Study Group},
title = {Successful response to tralokinumab in patients unresponsive, intolerant or with contraindications to dupilumab and JAK inhibitors: A case series},
journal = {Journal of the European Academy of Dermatology and Venereology},
year = {2024},
doi = {10.1111/jdv.19929}
}
EUVIMED